Equity
€86,578 from €205,612 in 2023
Equity fell by 58% in 2 years.
APOTHEEK BINNENHOF
Lifetime
8 annual accounts with figures on one time axispeak €215,379 (2021)
€189,226▲ 40.2%
lowest -€47,042 (2024)
€70,508▲ €117,550
peak €205,612 (2023)
€86,578▲ 98.7%
€667,601▼ 4.7%
peak 1.7 FTE (2018)
1.2 FTE▼ 20.0%
Board3 names since 2021
2 directorsDYSS and 1 other
Owners
100%DYSS
Documentsfilings and deeds
23-07-20268 days before the deadline
2025abbreviated format
Gross margin from €134,980 to €189,226Back to profit: €70,508Staff from 1.5 FTE to 1.2 FTEEquity from €43,570 to €86,578
Key points
from the 2025 annual accountsChecked score
71
Healthy
Financially stronger than 57% of micro companies in retail trade (NACE 47)
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,276 companies (NACE 47, micro).
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.4%lowest value
01-2025: 0.4%● unchanged vs 12-2024lowest value
02-2025: 0.4%● unchanged vs 01-2025lowest value
03-2025: 0.4%● unchanged vs 02-2025lowest value
04-2025: 0.4%● unchanged vs 03-2025
05-2025: 0.4%● unchanged vs 04-2025
06-2025: 0.4%● unchanged vs 05-2025
07-2025: 0.5%▲ +0.1 percentage points vs 06-2025
08-2025: 0.9%▲ +0.4 percentage points vs 07-2025
09-2025: 1.5%▲ +0.6 percentage points vs 08-2025
10-2025: 1.5%● unchanged vs 09-2025
11-2025: 1.5%● unchanged vs 10-2025
12-2025: 1.5%● unchanged vs 11-2025
01-2026: 1.5%● unchanged vs 12-2025
02-2026: 1.5%● unchanged vs 01-2026
03-2026: 1.5%● unchanged vs 02-2026
04-2026: 1.6%▲ +0.1 percentage points vs 03-2026
05-2026: 1.5%▼ -0.1 percentage points vs 04-2026
06-2026: 1.6%▲ +0.1 percentage points vs 05-2026
07-2026: 1.7%▲ +0.1 percentage points vs 06-2026highest value
08-2026: 0.7%▼ -1.0 percentage point vs 07-2026
09-2026: 0.7%● unchanged vs 08-2026
10-2026: 0.6%▼ -0.1 percentage points vs 09-2026
11-2026: 0.6%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Equity €86,578 (11.5% of total assets)
Sector: Retail trade (NACE 47)
lowers risk
Size: 1.2 FTE, total assets €754,179
Figures for financial year 2025 (filed on 23-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 28% of them on solvency, 49% on liquidity, 59% on profitability and 92% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,713 companies had the same profile as APOTHEEK BINNENHOF has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of APOTHEEK BINNENHOF itself: 0.6% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,713 companies, not a prediction for APOTHEEK BINNENHOF. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.41 (1.18 in 2024), below the usual 1.5. Short-term debt is 30.7% and cash 9.7% of total assets. 88.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 12838 sector peers (2025).
NBB · sector comparisonPosition among 12838 sector peers
Solvency
better than 22%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
8 days early
2024
27 days late
2023
28 days late
2022
30 days late
2021
2 days early
2020
3 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 10 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0699578351
Appointment: ARKLIN BV (director)
Permanent representative: Arkesteyn Inge · General meeting of 15-01-2024 · Gazette deed
1 director appointed, 1 resignation
Resignation: JONKERS Nadine · Appointment: DYSS BV · Permanent representative: Dassen Yves · General meeting of 01-06-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APOTHEEK BINNENHOF Tessenderlo-Ham | €754,179 | €189,226 | 11.5% | 1.2 |
| Apotheek De Niel Kristel Lommel | €634,141 | €192,869 | 37.6% | 1 |
| License to care Duffel | €702,743 | €200,921 | 2.6% | 1.1 |
| PHARMACIE KASSAR Schaerbeek | €776,098 | €188,778 | 16.6% | 1.5 |
| APOTHEEK ELISE DEMAÎTRE Oostrozebeke | €743,547 | €170,484 | 21.3% | 1 |
| Hove Pharma Hove | €849,286 | €198,814 | 26.8% | 1 |
| Apotheek Delrue Wielsbeke | €679,185 | €168,046 | 48.2% | 0.9 |
These companies have the same main activity as APOTHEEK BINNENHOF: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €634,000 and €849,000, founded between 2017 and 2019.
Official details
Source: KBO- Status
- Active since 03-07-2018Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 2 others
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.277.468.5423980 Tessenderlo-Ham, since 03-07-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 30-12-2025
Annual accounts 2025
- ≈ €880,000estimated
- €754,179▲ 1.3%
- Employeeson 31-12-2025
- 2=
- Filing
- Filed on 23-07-2026, 8 days before the end of the filing period
Insights on APOTHEEK BINNENHOF
APOTHEEK BINNENHOF files the abbreviated format. That format states no turnover. The gross margin rose from €160,938 in 2018 to €189,226 in 2025.
The balance sheet grew most from 2024 to 2025 through fixed assets, financed with long-term debt.
DYSS holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK BINNENHOF
- What is the company number of APOTHEEK BINNENHOF?
- The company number of APOTHEEK BINNENHOF is 0699.578.351. The VAT number is the same number with BE in front: BE 0699.578.351.
- Where is APOTHEEK BINNENHOF based?
- The registered office is at Binnenhof 14, 3980 Tessenderlo-Ham.Company details
- What does APOTHEEK BINNENHOF do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK BINNENHOF?
- APOTHEEK BINNENHOF is a private limited company (BV).
- When was APOTHEEK BINNENHOF founded?
- APOTHEEK BINNENHOF was founded on 03-07-2018.
- Is APOTHEEK BINNENHOF still active?
- Yes, APOTHEEK BINNENHOF is an active enterprise in the KBO register.
- How many employees does APOTHEEK BINNENHOF have?
- APOTHEEK BINNENHOF had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK BINNENHOF fall under?
- In its 2025 annual accounts, APOTHEEK BINNENHOF states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK BINNENHOF?
- The turnover in financial year 2025 is ≈ €880,000. This figure is estimated from the gross margin of €189,226 and 51 comparable companies (NACE 477). It probably lies between €590,000 and €1.7m.
- Is APOTHEEK BINNENHOF profitable?
- In financial year 2025, APOTHEEK BINNENHOF made a profit of €70,508.
- Where can I find the annual accounts of APOTHEEK BINNENHOF?
- APOTHEEK BINNENHOF filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK BINNENHOF due?
- APOTHEEK BINNENHOF must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.